CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Guaifenesin

perrigo

Perrigo Starting Shipments of Guaifenesin Extended-Release 600mg

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers

WWJ Newsradio 950–03/18/2013

perrigo

Perrigo Launches Generic Mucinex

Perrigo Co. (Nasdaq: PRGO) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg, a generic version of Mucinex 600mg tablets.

WWJ Newsradio 950–04/15/2012

perrigo

Perrigo Wins Summary Judgment in Generic Mucinex Case

Perrigo Co. announced that the United States District Court for the Western District of Michigan has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex tablets.

WWJ Newsradio 950–01/12/2012

perrigo

Perrigo Receives Final FDA Approval For Store Brand Equivalent Of Mucinex

Perrigo Co. received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Guaifenesin Extended-Release Tablets, 600 mg.

11/28/2011

Follow

Get every new post delivered to your Inbox.

Join 1,876 other followers